Clinical trials
Recherche d’études cliniques
Recherchez uniquement dans les études cliniques enregistrées dans Biomedical Watch.
Études cliniques 242
| Étude / NCT ⇅ | Molécule ⇅ | Maladie ⇅ | Phase ⇅ | Statut ⇅ | Résultat ⇅ | Sponsor ⇅ | Pays / centres ⇅ | Période ⇅ | Détail |
|---|---|---|---|---|---|---|---|---|---|
| NCT05648500 OPUS-1 — A Research Study to Evaluate the Effects of a New Oral Medicin… |
Cenerimod | Lupus | Phase 3 | ACTIVE_NOT_RECRUITING | En attente / non publié | Viatris Innovation GmbH | United States, Argentina, Brazil, Bulgaria, Colombia,… | 2022-12-13 → 2027-09-30 | Ouvrir |
| NCT07328581 A Phase IIa Study of ICG318 CAR-T in Refractory Systemic Lupus Erythema… |
ICG318, BCMA-CD19-IL-15/IL-15 sus… | Lupus | Phase 2 | RECRUITING | En attente / non publié | iCell Gene Therapeutics | United States · Fox Chase Cancer Center- Temple BMT, … | 2026-09 → 2028-12 | Ouvrir |
| NCT06987565 TvSSLE — Transcutaneous Vagus Nerve Stimulation in SLE |
Active vagus nerve stimulation | Lupus | Phase 2 | RECRUITING | En attente / non publié | Baylor Research Institute | United States · Feinstein Institutes for Medical Rese… | 2025-07-25 → 2027-09 | Ouvrir |
| NCT07447986 To Evaluate the Efficacy and Safety of SG301 SC Injection in Systemic L… |
SG301 SC Injection | Lupus | Phase 2 | RECRUITING | En attente / non publié | Hangzhou Sumgen Biotech Co., Ltd. | China · Changzhou Second People's Hospital, Changzhou… | 2026-03-26 → 2027-12-31 | Ouvrir |
| NCT06673043 SLE-ARTEMIS — Anifrolumab Real-world Treatment Outcomes in Systemic Lup… |
Anifrolumab | Lupus | À vérifier | ACTIVE_NOT_RECRUITING | En attente / non publié | University of Cambridge | Poland · Research Site, Bydgoszcz, Poland | Research … | 2025-02-28 → 2028-06-30 | Ouvrir |
| NCT05440422 The Role of Anifrolumab in Improving Markers of Vascular Risk in Patien… |
Anifrolumab | Lupus | Phase 2 | RECRUITING | En attente / non publié | University of Cambridge | United States · National Institutes of Health Clinica… | 2023-12-07 → 2027-08-02 | Ouvrir |
| NCT04902807 ATRACTion — Conception of a Diagnosis, Prognosis and Therapeutic Decisi… |
Collection of samples | Lupus | À vérifier | COMPLETED | En attente / non publié | Institut National de la Santé Et … | France · Hopital Necker Enfants Malades, Paris, France | 2021-09-07 → 2025-10-21 | Ouvrir |
| NCT07748156 SNC116 Therapy for Refractory Systemic Lupus Erythematosus |
SNC116 | Lupus | Phase 1 | NOT_YET_RECRUITING | En attente / non publié | The Affiliated Nanjing Drum Tower… | China · The Affiliated Nanjing Drum Tower Hospital of… | 2026-10 → 2030-01 | Ouvrir |
| NCT07085104 RESOLUTION — A Study to Investigate the Safety and Preliminary Efficacy… |
ALLO-329 | Lupus | Phase 1 | RECRUITING | En attente / non publié | Allogene Therapeutics | United States, Canada · Astera Cancer Care, East Brun… | 2025-11-13 → 2032-10 | Ouvrir |
| NCT00055055 Study of Families With Twins or Siblings Discordant for Rheumatic Disor… |
Study of Families With Twins or S… | Lupus | À vérifier | COMPLETED | En attente / non publié | National Institute of Environment… | United States · National Institutes of Health Clinica… | 2003-04-21 | Ouvrir |
| NCT05538208 The Pediatric Lupus Nephritis Mycophenolate Mofetil (PLUMM) Study |
Mycophenolate Mofetil | Lupus | Phase 2 | RECRUITING | En attente / non publié | Hoffmann-La Roche | United States · Akron Children's Hospital, Akron, Uni… | 2024-06-07 → 2027-01 | Ouvrir |
| NCT07607964 A Study to Assess Adverse Events, How the Drug Moves Through the Body a… |
ABBV-519 | Lupus | Phase 1 | RECRUITING | En attente / non publié | AbbVie | United States, Japan · Accurate Clinical Research - H… | 2026-05-28 → 2029-01 | Ouvrir |
| NCT07363590 A Clinical Study of MK-1045 in People With Lupus or Rheumatoid Arthriti… |
MK-1045 | Lupus | Phase 1 | RECRUITING | En attente / non publié | Merck Sharp & Dohme LLC | Australia, Belgium, China, Colombia, Georgia, Italy, … | 2026-02-19 → 2029-07-16 | Ouvrir |
| NCT06948110 Deciphering the Genetic Architecture of Autoimmune Diseases |
Deciphering the Genetic Architect… | Lupus | À vérifier | RECRUITING | En attente / non publié | National Human Genome Research In… | United States, Peru · Amazon Rainforest, Lima, Peru |… | 2026-09-17 → 2030-04-22 | Ouvrir |
| NCT05637112 ASTER — A Treatment Effectiveness Study Among SLE Patients Receiving An… |
ASTER — A Treatment Effectiveness… | Lupus | À vérifier | ACTIVE_NOT_RECRUITING | En attente / non publié | AstraZeneca | Austria, Belgium, Canada, France, Germany, Israel, It… | 2023-02-27 → 2030-12-30 | Ouvrir |
| NCT07800871 FT839 in Autoimmune Diseases |
FT839 | Lupus | Phase 1/2 | RECRUITING | En attente / non publié | Fate Therapeutics | United States · Providence Medical Foundation, Fuller… | 2026-10 → 2040-10 | Ouvrir |
| NCT07544225 CELL-ATTACK 1 — Study Investigating the Safety of Anti-CD19 CAR-T Cells… |
anti-CD19 CAR-T cells | Lupus | Phase 1 | NOT_YET_RECRUITING | En attente / non publié | Gustave Roussy, Cancer Campus, Gr… | France · Gustave Roussy, Villejuif, France | 2026-12-01 → 2043-02-01 | Ouvrir |
| NCT07805863 Serum MPO-DNA Complexes as a Biomarker of Disease Activity in Systemic … |
Serum MPO-DNA Complexes as a Biom… | Lupus | À vérifier | NOT_YET_RECRUITING | En attente / non publié | Assiut University | Non communiqué | 2026-10 → 2027-11 | Ouvrir |
| NCT00001372 Study of Systemic Lupus Erythematosus |
Study of Systemic Lupus Erythemat… | Lupus | À vérifier | RECRUITING | En attente / non publié | National Institute of Arthritis a… | United States · National Institutes of Health Clinica… | 1994-02-10 | Ouvrir |
| NCT06530849 A Study of GC012F Injection in Subjects With Refractory Systemic Lupus … |
GC012F Injection | Lupus | Phase 1/2 | ACTIVE_NOT_RECRUITING | En attente / non publié | Gracell Biotechnologies (Shanghai… | China · Research Site, Shanghai, China | Research Sit… | 2024-08-22 → 2027-02-01 | Ouvrir |
| NCT06875960 A Study to Continue the Administration of Deucravacitinib in Participan… |
BMS-986165 | Lupus | Phase 4 | RECRUITING | En attente / non publié | Bristol-Myers Squibb | United States · Local Institution - 0001, Farmington,… | 2026-02-24 → 2028-01-31 | Ouvrir |
| NCT06717815 Phase IIa Study for IPG11406 in Patients With Lupus Nephritis |
IPG11406 | Lupus | Phase 1/2 | COMPLETED | En attente / non publié | Nanjing Immunophage Biotech Co., … | China · Fujian Medical University Union Hospital, Fuz… | 2025-02-25 → 2026-06-08 | Ouvrir |
| NCT07810569 Ocular Surface Changes and Meibomian Gland Dysfunction in Rheumatologic… |
Ocular Surface Changes and Meibom… | Lupus | À vérifier | NOT_YET_RECRUITING | En attente / non publié | Assiut University | Non communiqué | 2026-10 → 2027-11 | Ouvrir |
| NCT07814664 Ivarmacitinib Versus Glucocorticoids in Mild-to-Moderate Systemic Lupus… |
Ivarmacitinib Sulfate Tablets | Lupus | Phase 2/3 | NOT_YET_RECRUITING | En attente / non publié | Chinese SLE Treatment And Researc… | China · Peking Union Medical College Hospital, Beijin… | 2026-10-15 → 2028-09-30 | Ouvrir |
| NCT06475742 OPUS OLE — Long-term Safety and Tolerability of Cenerimod in Adults Wit… |
Cenerimod | Lupus | Phase 3 | ENROLLING_BY_INVITATION | En attente / non publié | Viatris Innovation GmbH | United States, Argentina, Brazil, Bulgaria, Chile, Co… | 2024-07-30 → 2032-09 | Ouvrir |